Measurement of Lipoprotein(a): A Once in a Lifetime Opportunity
- PMID: 35177191
- DOI: 10.1016/j.jacc.2021.11.053
Measurement of Lipoprotein(a): A Once in a Lifetime Opportunity
Keywords: clinical trials; coronary artery disease; lipoprotein(a); repeat measurements; risk threshold.
Conflict of interest statement
Funding Support and Author Disclosures Dr Marcovina has consulting roles for Roche, Denka, and Novartis; and has received research support from Amgen through Medpace. Dr Shapiro has participated in the Scientific Advisory Board for Amgen, Esperion, Novartis, and Novo Nordisk.
Comment on
-
Repeat Measures of Lipoprotein(a) Molar Concentration and Cardiovascular Risk.J Am Coll Cardiol. 2022 Feb 22;79(7):617-628. doi: 10.1016/j.jacc.2021.11.055. J Am Coll Cardiol. 2022. PMID: 35177190 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
